Crosstalk Between GABAergic Neurotransmission and Inflammatory Cascades in the Post-ischemic Brain: Relevance for Stroke Recovery
- PMID: 35401118
- PMCID: PMC8983863
- DOI: 10.3389/fncel.2022.807911
Crosstalk Between GABAergic Neurotransmission and Inflammatory Cascades in the Post-ischemic Brain: Relevance for Stroke Recovery
Abstract
Adaptive plasticity processes are required involving neurons as well as non-neuronal cells to recover lost brain functions after an ischemic stroke. Recent studies show that gamma-Aminobutyric acid (GABA) has profound effects on glial and immune cell functions in addition to its inhibitory actions on neuronal circuits in the post-ischemic brain. Here, we provide an overview of how GABAergic neurotransmission changes during the first weeks after stroke and how GABA affects functions of astroglial and microglial cells as well as peripheral immune cell populations accumulating in the ischemic territory and brain regions remote to the lesion. Moreover, we will summarize recent studies providing data on the immunomodulatory actions of GABA of relevance for stroke recovery. Interestingly, the activation of GABA receptors on immune cells exerts a downregulation of detrimental anti-inflammatory cascades. Conversely, we will discuss studies addressing how specific inflammatory cascades affect GABAergic neurotransmission on the level of GABA receptor composition, GABA synthesis, and release. In particular, the chemokines CXCR4 and CX3CR1 pathways have been demonstrated to modulate receptor composition and synthesis. Together, the actual view on the interactions between GABAergic neurotransmission and inflammatory cascades points towards a specific crosstalk in the post-ischemic brain. Similar to what has been shown in experimental models, specific therapeutic modulation of GABAergic neurotransmission and inflammatory pathways may synergistically promote neuronal plasticity to enhance stroke recovery.
Keywords: GABA; chemokine; glutamate decarboxylate; immune cell; inflammation; neurotransmission; stroke recovery.
Copyright © 2022 Michalettos and Ruscher.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Effect of Anti-inflammatory Treatment with AMD3100 and CX3CR1 Deficiency on GABAA Receptor Subunit and Expression of Glutamate Decarboxylase Isoforms After Stroke.Mol Neurobiol. 2021 Nov;58(11):5876-5889. doi: 10.1007/s12035-021-02510-x. Epub 2021 Aug 20. Mol Neurobiol. 2021. PMID: 34417725 Free PMC article.
-
gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia.J Neurochem. 2001 Apr;77(2):353-71. doi: 10.1046/j.1471-4159.2001.00274.x. J Neurochem. 2001. PMID: 11299298 Review.
-
Triiodothyronine modulates neuronal plasticity mechanisms to enhance functional outcome after stroke.Acta Neuropathol Commun. 2019 Dec 21;7(1):216. doi: 10.1186/s40478-019-0866-4. Acta Neuropathol Commun. 2019. PMID: 31864415 Free PMC article.
-
An integrated measure of GABA to characterize post-stroke plasticity.Neuroimage Clin. 2023;39:103463. doi: 10.1016/j.nicl.2023.103463. Epub 2023 Jun 25. Neuroimage Clin. 2023. PMID: 37406594 Free PMC article. Review.
-
GABAergic signalling in the immune system.Acta Physiol (Oxf). 2015 Apr;213(4):819-27. doi: 10.1111/apha.12467. Epub 2015 Mar 1. Acta Physiol (Oxf). 2015. PMID: 25677654 Review.
Cited by
-
Exploring the "gene-metabolite" network of ischemic stroke with blood stasis and toxin syndrome by integrated transcriptomics and metabolomics strategy.Sci Rep. 2024 May 25;14(1):11947. doi: 10.1038/s41598-024-61633-y. Sci Rep. 2024. PMID: 38789486 Free PMC article.
-
Signal detection of adverse events associated with gabapentinoid use for chronic pain.Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5685. doi: 10.1002/pds.5685. Epub 2023 Aug 28. Pharmacoepidemiol Drug Saf. 2024. PMID: 37640024 Free PMC article.
-
Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options.Mediators Inflamm. 2022 Oct 11;2022:6508046. doi: 10.1155/2022/6508046. eCollection 2022. Mediators Inflamm. 2022. PMID: 36267243 Free PMC article. Review.
-
Does activation of oxytocinergic reward circuits postpone the decline of the aging brain?Front Psychol. 2023 Dec 29;14:1250745. doi: 10.3389/fpsyg.2023.1250745. eCollection 2023. Front Psychol. 2023. PMID: 38222845 Free PMC article. Review.
-
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease.Biomedicines. 2022 Jul 19;10(7):1743. doi: 10.3390/biomedicines10071743. Biomedicines. 2022. PMID: 35885050 Free PMC article. Review.
References
-
- Andres R. H., Choi R., Pendharkar A. V., Gaeta X., Wang N., Nathan J. K., et al. . (2011). The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42, 2923–2931. 10.1161/STROKEAHA.110.606368 - DOI - PMC - PubMed
-
- Barnard E. A., Skolnick P., Olsen R. W., Mohler H., Sieghart W., Biggio G., et al. . (1998). International union of pharmacology. XV. subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313. - PubMed
Publication types
LinkOut - more resources
Full Text Sources